Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic ...
Nine percent of Alabamans live with chronic obstructive pulmonary disease (COPD) a long-term, progressive lung disease that causes difficulty breathing. In fact, Alabama is one of the top 10 states in ...
More than 8% of Hoosiers live with chronic obstructive pulmonary disease (COPD), a long-term, progressive lung disease that causes difficulty breathing. In fact, Indiana is one of the top 10 states in ...
Chronic Obstructive Pulmonary Disease (COPD) is a long-term, inflammatory lung condition that causes airflow obstruction and reduced lung function. In short, COPD makes it hard to breathe.
TAIPEI (Taiwan News) — Extreme weather can affect people with chronic obstructive pulmonary disease, a long-term lung condition, a recent study from Taiwan shows. The research, published in Science of ...
The Insomnia and Sleep Health Patient Education Center contains patient-friendly information about insomnia and related sleep disorders, including sleep apnea, narcolepsy, and restless legs syndrome.
Board-certified orthopedic surgeon Benjamin W. Szerlip, DO has launched the ShoulderWise Podcast, a new educational resource designed to help patients and healthcare professionals better understand ...
Abstract: Pulmonary emphysema overlaps considerably with chronic obstructive pulmonary disease (COPD), and is traditionally subcategorized into three subtypes previously identified on autopsy.
Key domains in clinical care where AI has the potential to drive improvements, including predictive analytics for events and complications, clinical decision support systems, personalized care ...
Correspondence to Dr Sami O Simons, Department of Respiratory Medicine, Maastricht University Medical Centre, 6202 AZ Maastricht, The Netherlands; sami.simons{at}mumc.nl Coronavirus SARS-CoV-2 is ...
Peripheral artery disease (PAD) is a common cardiovascular disease associated with increased risk of amputation, myocardial infarction, stroke, and death, as well as impaired quality of life (QOL), ...
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
4 China Medical University College of Chinese Medicine, Taichung, Taiwan Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results